908 Devices Inc.

NASDAQ:MASS

Medical - Devices

Healthcare
$9.52 +2.51%

+$0.22 today

Market cap
$395.86M
Beta
0.64
P/E (TTM)
-9.0
EPS (TTM)
-$0.97
52W Low $5.03High $9.34

Volume 0.25M

Average 0.27M

MASS EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

908 Devices Inc.NASDAQ: MASS

EBITDA · Q1 FY2026 · quarter ended Mar 2026

EBITDA remains negative

Q1 FY2026 EBITDA was -$10.82M, compared with -$7.24M a year earlier. Trailing-twelve-month EBITDA was -$26.57M.

Context

  • EBITDA amounted to 51.4% of revenue in FY2025, down 22.2 pp from a year earlier.
  • EBITDA grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 5 analysts of -$2.1M (+92.7%) for the fiscal year ending Dec 2026, a step up from the +34.2% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$10.82M-299.1% QoQ
Last fiscal yearDec 2025
-$28.88M+34.2% YoY
LTMMar 2026
-$26.57M+5.3% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-49.5%+39.6%+89.0 pp
1 year+34.2%+92.7%+58.5 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
(28.88M) USD
Year-over-year change
+34.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How MASS compares with its peers on the latest reported figures

  • MASS's LTM Mar 2026 EBITDA of -$26.57M is the lowest of the 3 companies compared; the peer median is $1.37B.
  • Its year-over-year change of +5.3% is the 2nd highest of 3, against a peer median of +5.8%.
  • EBITDA amounts to 46.0% of revenue for MASS, versus a peer median of 30.5%.
MASS Competitors Peer median
EBITDA for MASS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AAgilent Technologies, Inc.LTM Jul 2026$2.04B +13.2%-1.2%27.6%
QGENQiagen N.V.LTM Jun 2026$703.39M -1.6%-2.7%33.5%
MASS908 Devices Inc.LTM Mar 2026-$26.57M +5.3%—46.0%
Peer median (excluding MASS) $1.37B+5.8%-2.0%30.5%

Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue42.21M46.85M50.23M59.63M56.2M
Cost of Revenue18.97M20.83M24.91M29.71M29.4M
Gross Profit23.23M26.02M25.32M29.93M26.8M
Gross Margin55.0%55.5%50.4%50.2%47.7%
Research & Development13.07M17.53M21.9M25.5M13.8M
Selling, General & Admin32.24M43.88M0037.18M
Operating Expenses45.3M61.41M68.08M106.64M50.98M
Depreciation & Amortization925K1.61M2.38M4.68M4.47M
EBITDA(20.76M)(31.82M)(40.27M)(43.88M)(28.88M)
EBITDA Margin-49.2%-67.9%-80.2%-73.6%-51.4%
Operating Income(22.07M)(35.38M)(42.76M)(76.72M)(24.18M)
Operating Margin-52.3%-75.5%-85.1%-128.7%-43.0%
Interest Income548K2.03M6.48M4.49M4.14M
Interest Expense486K129K201K00
Other Income / Expenses(100K)1.82M6.15M4.23M(9.16M)
Income Before Tax(22.17M)(33.56M)(36.61M)(72.49M)(33.34M)
Pre-Tax Margin-52.5%-71.6%-72.9%-121.6%-59.3%
Income Tax Expense00(211K)(282K)(66K)
Net Income(22.17M)(33.56M)(36.4M)(72.21M)(36.64M)
Net Margin-52.5%-71.6%-72.5%-121.1%-65.2%
EPS (Basic)(0.79)(1.07)(1.13)(2.12)0.54
EPS (Diluted)(0.79)(1.07)(1.13)(2.12)0.54
Weighted Avg Shares27.96M31.49M32.21M34.08M36.22M
Weighted Avg Shares (Diluted)27.96M31.49M32.24M34.08M38.92M

908 Devices Inc.

NASDAQ:MASS

Intrinsic Alpha fair value

Locked

Current Price

$9.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.